| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
229,747
|
212,837
|
219,020
|
192,907
| | Cost of Revenue | 119,822 | 115,663 | 122,368 | 114,115 | | |
Gross Profit
|
109,925
|
97,174
|
96,652
|
78,792
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 13,449 | 67,523 | 19,882 | 14,238 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others | 32,440 | 35,991 | 27,528 | 26,675 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
64,036
|
(6,340)
|
49,242
|
37,879
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 4,899 | 4,804 | 4,747 | 2,958 |
|
Earnings Before Interest And Taxes | 68,935 | (1,536) | 53,989 | 40,837 |
|
Interest Expense | 11,811 | 11,942 | 10,977 | 9,560 |
|
Income Before Tax | 57,124 | (13,478) | 43,012 | 31,277 |
|
Income Tax Expense | 4,236 | 559 | 72 | (3,802) |
|
Minority Interest | (2,231) | (2,934) | (3,423) | (4,290) |
|
|
|
Net Income From Continuing Ops | 50,657 | (16,971) | 39,517 | 30,789 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
50,657
|
(16,971)
|
39,517
|
30,789
| | Preferred Stock And Other Adjustments |
-
|
-
| 10,466 | (10,466) | | |
Net Income Applicable To Common Shares
|
50,657
|
(16,971)
|
49,983
|
20,323
|
|
0.29(0.48%) 3:31PM EDT - Nasdaq Real Time Price